Regulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense against Plasmodium falciparum Infection
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Iron chelation therapy of Plasmodium falciparum infection alleviates the clinical course of cerebral malaria in children. This study assessed the underlying mechanisms of this therapy. Cytokine stimulation of human (intestinal cell line DLD-1) or murine cells (murine macrophage cell line RAW 264.7) resulted in increased nitric oxide (NO) formation and decreased survival of plasmodia within cocultured human erythrocytes. The addition of desferrioxamine (DFO) before cytokine treatment increased both NO formation and parasite killing but had no effect in the presence of the inhibitor of NO formation, L-N6-(1-iminoethyl)-lysine. Moreover, peroxynitrite, which is formed after chemical reaction of NO with superoxide, appears to be the principal effector molecule for macrophage-mediated cytotoxicity toward P. falciparum, and interferon-gamma is a major regulatory cytokine for this process. The effect of DFO on the clearance of plasmodia appears to be due to enhanced generation of NO, rather than to limitation of iron availability to the parasite.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pathway appears to be partly responsible for the beneficial clinical effects of iron chelators observed in several experimental infection systems (Mencacci et al., 1997; Fritsche et al., 2001; Ibrahim et al., 2007; Bellmann-Weiler et al., 2013; Nairz et al., 2013).”
From Iron at the interface of immunity and infection (2014) · cites this paper as Fritsche et al., 2001
In the citing paper
“the malarial parasite Plasmodium falciparum requires considerable iron for growth, and there is evidence that lowering the amount of available iron provides a promising route to antimalarials (e.g. [1478-1494]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1487]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077 · cited 1×
“The concentration of nitrite in tissue culture supernatants was determined by the Griess reaction [20].”
MethodNITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211 · cited 3×
“stimulation by cytokines such as TNF-a, IL-1/3 and/or IFN-,yl LPS appears to be a pivotal antiplasmodial effector mechanism [9].”
BackgroundBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615 · cited 3×
“, vascular relaxation, neurotransmission, and cellular cytotoxicity) against various microorganisms [9, 10].”
BackgroundRedox signaling: Nitrosylation and related target interactions of nitric oxide
Stamler, J. S. (1994) · Cell · doi:10.1016/0092-8674(94)90269-0 · Cited by 1,723 · cited 1×
“Because NO and 02- together form ONOO [25, 26], this short-lived radical probably is the major effector molecule for antiplasmodial activity of cytokine-stimulated macrophages.”
BackgroundFree radicals and phagocytic cells
Rosen, G. M., Pou, S., Ramos, C. L., Cohen, M. S., & Britigan, B. E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7540156 · Cited by 478 · cited 1×
“It is well established that, as a major cytotoxic effector mechanism, monocytes/macrophages produce and excrete toxic oxygen compounds, such as hydroxyl radicals, superoxide anion, or hydrogen peroxide, after stimulation with IFN-y [10, 23].”
BackgroundIron regulates nitric oxide synthase activity by controlling nuclear transcription.
Weiss, G., Werner-Felmayer, G., Werner, E. R., Grünewald, K., Wachter, H., & Hentze, M. W. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.969 · Cited by 412 · cited 3×
“This was of interest because of in vitro data showing that iron inhibits the formation of NO by a transcriptional mechanism [17], which leads to reduced binding of NF-IL6 to the iNOS promoter [18], and because of in vivo data showing increased serum nitrite and nitrate levels in children receiving DFO in addition to s…”
BackgroundResultSelf-citationBiosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Drapier, J. C., Hirling, H., Wietzerbin, J., Kaldy, P., & Kühn, L. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06038.x · Cited by 401 · cited 1×
“NO regulates the expression of critical mRNAs in cellular iron metabolism, namely ferritin and transferrin receptor mRNA at the posttranscriptional levels via activation of iron regulatory proteins [15, 16], and iron inhibits the expression of inducible NO synthase (iNOS), the enzyme responsible for high-output format…”
BackgroundTranslational regulation via iron‐responsive elements by the nitric oxide/NO‐synthase pathway.
Weiss, G., Goossen, B., Doppler, W., Fuchs, D., Pantopoulos, K., Werner‐Felmayer, G., Wachter, H., & Hentze, M. W. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06039.x · Cited by 389
Synthesis of nitrite and nitrate in murine macrophage cell lines.
Stuehr, D. J., & Marletta, M. A. (1987) · PubMed · Cited by 378
Iron metabolism in health and disease
Baldus, W. P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90247-3 · Cited by 377
Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria
Clark, I. A., & Hunt, N. H. (1983) · Infection and Immunity · doi:10.1128/iai.39.1.1-6.1983 · Cited by 356 · cited 1×
“Moreover, oxygen radicals have been implicated as having an important role in antiplasmodial toxicity [24].”
BackgroundKilling of Plasmodium falciparum in vitro by nitric oxide derivatives
Rockett, K. A., Awburn, M. M., Cowden, W. B., & Clark, I. A. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3280-3283.1991 · Cited by 306 · cited 1×
“NO also has an important role in host defense against malaria parasites [11-14].”
BackgroundIron metabolism in health and disease
Brock, J. H., Halliday, J. W., Pippard, M. J., & Powell, L. W. (1994) · Cited by 286
Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272101 · Cited by 210 · cited 3×
“antimalarial therapy with quinine resulted in faster recovery from coma, shorter duration of fever, and faster clearance of parasites from the blood circulation [4, 5]; however, the background for this effect of iron chelation therapy is poorly understood, although it is well established that iron and heme are essenti…”
BackgroundPeroxynitrite: reactive, invasive and enigmatic
Groves, J. T. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80036-2 · Cited by 206 · cited 1×
“It is well known that the production and release of ONOO- is detrimental to target cells in vivo by oxidizing and nitrating of proteins, lipids, or DNA [9, 27, 28].”
BackgroundMayer, B., Schrammel, A., Klatt, P., Koesling, D., & Schmidt, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17355 · Cited by 195
Dlaska, M., & Weiss, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6171 · Cited by 176 · cited 2×
“This was of interest because of in vitro data showing that iron inhibits the formation of NO by a transcriptional mechanism [17], which leads to reduced binding of NF-IL6 to the iNOS promoter [18], and because of in vivo data showing increased serum nitrite and nitrate levels in children receiving DFO in addition to s…”
BackgroundNüssler, A., Drapier, J., Rénia, L., Pied, S., Miltgen, F., Gentilini, M., & Mazier, D. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210134 · Cited by 176 · cited 1×
“NO also has an important role in host defense against malaria parasites [11-14].”
BackgroundSchwarzer, E., Alessio, M., Ulliers, D., & Arese, P. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1601-1606.1998 · Cited by 173
(1992) · PubMed · Cited by 127
Self-citationMalaria: New Developments in Treatment and Prevention
Newton, B., & White, D. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.179 · Cited by 126 · cited 1×
“Although several chemotherapeutic agents are available, pharmacologic therapy sometimes is insufficient, so there is a need for the development of new drugs [2, 3].”
BackgroundDeferoxamine inhibition of malaria is independent of host iron status.
Hershko, C., & Peto, T. E. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.1.375 · Cited by 124 · cited 1×
“Previous data indicate that the growth-limiting effect of DFO on parasites cannot be attributed exclusively to restriction of iron availability to the pathogen [6], and it has been suggested that this beneficial effect of DFO could be due to immune”
BackgroundStatus of antimalarial drugs under development.
Olliaro, P., & Trigg, P. I. (1995) · Europe PMC (PubMed Central) · Cited by 95
Mellouk, S., Hoffman, S. L., Liu, Z. Z., de la Vega, P., Billiar, T. R., & Nussler, A. K. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4043-4046.1994 · Cited by 94 · cited 1×
“NO also has an important role in host defense against malaria parasites [11-14].”
BackgroundGordeuk, V., Thuma, P., Brittenham, G., Zulu, S., Simwanza, G., Mhangu, A., Flesch, G., & Parry, D. (1992) · Blood · doi:10.1182/blood.v79.2.308.308 · Cited by 90
Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria
Thuma, P. E., Mabeza, G. F., Biemba, G., Bhat, G. J., McLaren, C. E., Moyo, V. M., Zulu, S., Khumalo, H., Mabeza, P., M'Hango, A., et al. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90753-2 · Cited by 76 · cited 1×
“However, although the addition of DFO to antimalarial therapy resulted in faster recovery from coma, shorter duration of fever, and increased clearance of plasmodia from the circulation [4], the survival rates in children receiving either placebo or DFO were not different [30].”
BackgroundChiwakata, C. B., Hemmer, C. J., & Dietrich, M. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.394-399.2000 · Cited by 73
Modulatory Potential of Iron Chelation Therapy on Nitric Oxide Formation in Cerebral Malaria
Weiss, G., Thuma, P. E., Mabeza, G., Werner, E. R., Herold, M., & Gordeuk, V. R. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.1.226 · Cited by 52 · cited 4×
“This was of interest because of in vitro data showing that iron inhibits the formation of NO by a transcriptional mechanism [17], which leads to reduced binding of NF-IL6 to the iNOS promoter [18], and because of in vivo data showing increased serum nitrite and nitrate levels in children receiving DFO in addition to s…”
BackgroundMethodSelf-citationInvolvement of protein kinases in the induction of NO synthase II in human DLD‐1 cells
Kleinert, H., Euchenhofer, C., Fritz, G., Ihrig‐Biedert, I., & Förstermann, U. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701782 · Cited by 37
Cited by
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Melanogenesis and associated cytotoxic reactions: Applications to insect innate immunity
Nappi, A. J., & Christensen, B. M. (2005) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2005.01.014 · Cited by 675
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[1320-1336], but cf.”
Mechanisms of nutrient modulation of the immune response
Cunningham-Rundles, S., McNeeley, D. F., & Moon, A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.04.036 · Cited by 534
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
Self-citation
Metadata
- Authors
- Fritsche, G., Larcher, C., Schennach, H., & Weiss, G.
- Affiliations
- University Hospital Innsbruck (AT)
- Innsbruck Medical University (AT)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05
- Volume
- 183
- Issue
- 9
- Pages
- 1388-1394
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2137614946
- Cited by
- 84
- References
- 31
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- Plasmodium falciparum, cerebral malaria, iron chelation therapy, deferoxamine, nitric oxide, peroxynitrite, macrophage cytotoxicity, interferon-gamma, cytokine regulation, parasite clearance, immune defense, iron metabolism
- MeSH terms
- Animals, Cells, Cultured, Deferoxamine, Erythrocytes, Humans, Interferon-gamma, Iron, Iron Chelating Agents, Lipopolysaccharides, Macrophages, Nitric Oxide, Plasmodium falciparum, RNA, Messenger, Superoxide Dismutase, Tumor Cells, Cultured, Malaria, Falciparum, Coculture Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.